T2 Biosystems Inc (NASDAQ: TTOO) is -41.43% lower on its value in year-to-date trading and has touched a low of $0.22 and a high of $6.95 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TTOO stock was last observed hovering at around $0.23 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $0.25, the stock is -27.74% and -42.09% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.95 million and changing 7.33% at the moment leaves the stock -91.04% off its SMA200. TTOO registered -94.45% loss for a year compared to 6-month loss of -95.08%. The firm has a 50-day simple moving average (SMA 50) of $0.4341 and a 200-day simple moving average (SMA200) of $2.75996.
The stock witnessed a -26.37% gain in the last 1 month and extending the period to 3 months gives it a -82.80%, and is -12.14% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.47% over the week and 12.86% over the month.
T2 Biosystems Inc (TTOO) has around 113 employees, a market worth around $6.90M and $7.68M in sales. Profit margin for the company is -559.52%. Distance from 52-week low is 13.89% and -96.46% from its 52-week high.
24.0 institutions hold shares in T2 Biosystems Inc (TTOO), with institutional investors hold 81.83% of the company’s shares. The shares outstanding are 18.76M, and float is at 12.48M with Short Float at 7.55%. Institutions hold 73.51% of the Float.
T2 Biosystems Inc (TTOO) Insider Activity
The most recent transaction is an insider sale by Elsbree David B, the company’s Director. SEC filings show that Elsbree David B sold 55 shares of the company’s common stock on Sep 13 ’24 at a price of $2.42 per share for a total of $133.0. Following the sale, the insider now owns 23.0 shares.
